This inventor holds 4 USPTO granted patents. Top assignee: Ligand Pharmaceuticals, Inc.. Active years: 1996-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1998
Title: Youssef L. Bennani: Innovator in Pharmaceutical Technologies
Introduction
Youssef L. Bennani is a notable inventor based in La Jolla, California, recognized for his contributions to the field of pharmaceutical technologies. With a commendable portfolio of four patents, he has made significant strides in the development of novel compounds that have important therapeutic implications.
Latest Patents
Among his latest innovations are patents focusing on tricyclic retinoids. These compounds exhibit activity for retinoic acid receptors and retinoid X receptors, offering promising avenues for treatment. The patents not only detail the production methods for these tricyclic retinoids but also outline their use in pharmaceutical compositions and therapeutic applications, underscoring their potential benefits in medical science.
Career Highlights
Youssef L. Bennani is currently affiliated with Ligand Pharmaceuticals, Inc., a company known for its commitment to improving patient outcomes through innovative therapies. His work at Ligand highlights his role as a key contributor to advancements in drug development, particularly in the realm of retinoid-based treatments.
Collaborations
Throughout his career, Youssef has collaborated with other notable professionals, including Alex M. Nadzan and Chan Kou Hwang. This teamwork has facilitated the exchange of ideas and expertise, fostering an environment conducive to groundbreaking research and innovation.
Conclusion
Youssef L. Bennani stands out as an influential figure in the realm of pharmaceutical sciences. His innovative patents and collaborative spirit contribute to advancements that may enhance therapeutic options in the medical field, reflecting his commitment to improving healthcare through scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
